$4.630
+0.975 (+21.05%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
GLMD-Prognose durch Analyse ähnlicher Charts
Alphio's GLMD stock price prediction model matches the current Galmed Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.58 (-1.17%). The 1-week path is $4.68 (+1.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Galmed Pharmaceuticals Ltd-Aktien kaufen?
Galmed Pharmaceuticals Ltd is not a good buy right now due to its declining stock performance and negative financial indicators. The current price is $3.88, with a year-to-date change of -41.06% and a one-year change of -64.60%. Additionally, the company reported a last earnings EPS of -2.86, indicating ongoing losses. The RSI is at 33.289, suggesting the stock is oversold but may not recover soon given the persistent negative net income figures, such as -4,818,000 USD in Q4 2025. The main risk is the continued negative earnings trend, which has resulted in a forward P/E ratio of 0, indicating no earnings growth is expected in the near future.
GLMD schloss am Wednesday bei $4.63, nachdem der Kurs +21.05% gestiegen ist
Galmed Pharmaceuticals Ltd (GLMD) last closed at $4.63, gaining +21.05%. These facts feed the 1-day and 1-week GLMD price prediction above.
Analystenkonsens
Galmed Pharmaceuticals Ltd (GLMD): 5 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Galmed Pharmaceuticals Ltd (GLMD) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf GLMD am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für GLMD
Historically the probability of a positive November return for GLMD is 0.00%. January offers the highest probability of a positive month at 26.23%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für GLMD
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $2.02 | $2.21 | $2.36 | -52.27% |
| Dec 2026 | $2.00 | $2.21 | $2.24 | -52.27% |
Für 2026 wird für Galmed Pharmaceuticals Ltd (GLMD) eine Spanne von $2.00 bis $2.36 projiziert.
Monatsprognose 2026 für Galmed Pharmaceuticals Ltd
Im Nov 2026 wird für Galmed Pharmaceuticals Ltd ein Durchschnitt von $2.21 erwartet, mit einem Tief von $2.02 und einem Hoch von $2.36.
Im Dec 2026 wird für Galmed Pharmaceuticals Ltd ein Durchschnitt von $2.21 erwartet, mit einem Tief von $2.00 und einem Hoch von $2.24.
Ähnliche Artikel
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.